Recent events
Recent events tied to this brand in public sources.
Back to profile1 entries
2021
Immunai raises $215 million in Series B funding
Immunai raised $215 million in a Series B funding round led by Koch Disruptive Technologies. The article says the company planned to use the funds to expand its drug actuary platform.